glp-1 prescriptions growth q1 2025 The United States Agonists Weight Loss Drugs Market Size & Outlook, 2030 Monitoring Report: GLP-1 RA Prescribing

Medical Monitoring Regular assessment of bone health is essential for those on GLP-1 medications: Baseline DEXA scan : Consider getting a bone density test before starting GLP-1 medication Follow-up testing : Repeat every 1-2 years while on medication Blood tests : Check vitamin D, calcium, and bone turnover markers annually Height measurement : Loss of height can be an early warning sign of vertebral fractures Conclusion GLP-1 medications offer powerful benefits for weight management and diabetes control

In the U.S., about 6% of adults currently use GLP-1s, and 12% have used them in the past (2024 data) (Mozafariun 2025)

Svane MS, Bojsen-Moller KN, Nielsen S, Jorgensen NB, Dirksen C, Bendtsen F, et al

Petroni, M

Notably, a 503 B pharmacy has an additional layer of regulation (by the FDA) and may provide an additional level of quality assurance

At Centra Internal Medicine, we understand that beginning a medical weight loss journey comes with many questions regarding expectations and timelines